November 10, 2017 Licensing, IP, and Legal Life Science Tools

ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services

DUBLIN, Ireland, and Mountain View, CA, November 10, 2017 – ERS Genomics Ltd. and Cellecta, Inc. announced today a non-exclusive license agreement to provide Cellecta with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property for use in informing research tools and services. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, who... Read more

October 2, 2017 Life Science Tools Product Launch

Cellecta, Inc. Introduces CRISPRa and CRISPRi Genome-Wide sgRNA Libraries and Mouse Genome-Wide CRISPR Knockout Library to Expand Functional Genomic Screening Portfolio

Launch of new human and mouse genome-wide CRISPR gene activation and inhibition libraries and mouse knockout library will provide greater insights into gene function and accelerate drug target discovery efforts MOUNTAIN VIEW, Calif., Oct. 2, 2017 /PRNewswire/ — Cellecta, Inc. today introduced CRISPRa (for activation) and CRISPRi (for inhibition) genome-wide, human and mouse pooled screening libraries to its... Read more

March 29, 2017 Life Science Tools Product Launch

Cellecta, Inc. Launches Driver-Map™ Human Genome-Wide Gene Expression Profiling Kit for 19,000 Human Genes

Targeted RNA Expression Profiling Assay Combines the Specificity and Ease-of-Use of RT-PCR with the Ultra-Sensitivity and Throughput of Next-Generation Sequencing NEWS PROVIDED BY Cellecta, Inc. 29 Mar, 2017, 08:30 ET SHARE THIS ARTICLE MOUNTAIN VIEW, Calif., March 29, 2017 /PRNewswire/ — Cellecta, Inc. today announced the launch of the Driver-Map™ Human Genome-Wide Gene Expression Profiling kit,... Read more

January 26, 2017 Life Science Tools PR/Corporate

Cellecta, Inc. Receives Phase II NIH SBIR Grant to Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform

Development of a high-performance tool set for human and mouse genetic screens to enable enhanced drug discovery underway NEWS PROVIDED BY Cellecta, Inc. 26 Jan, 2017, 08:40 ET SHARE THIS ARTICLE MOUNTAIN VIEW, Calif., Jan. 26, 2017 /PRNewswire/ — Cellecta, Inc. today announced the receipt of Phase II SBIR grant funds from the National Institute of... Read more